# Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals

> **NCT00825123** · PHASE4 · TERMINATED · sponsor: **Bayside Health** · enrollment: 2 (actual)

## Conditions studied

- Central Arterial Pressure

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Metoprolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00825123
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2011-11-08
- **Final completion:** 2011-11-08
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2020-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00825123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00825123, "Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00825123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*